The impact of a patient navigator on readiness assessment scores in youth transitioning to adult health care in Alberta Authors: Megan Patton, Cassandra Chisholm, Zoya Punjwani, Andrew S Mackie, Scott Patten, Daniella San-Martin Feeney, Samantha J Anthony, Gina Dimitropoulos, Susan Samuel Published: 2026 ABSTRACT AbstractBackgroundAt ages 16–21, youth with chronic medical conditions transition from pediatric to adult specialty care and often feel unprepared. Transition readiness assessments, including the validated Transition Readiness Assessment Questionnaire (TRAQ), may guide preparation; however, longitudinal evaluation is needed to determine their utility in supporting successful transitions.Objective(1) To compare changes in TRAQ scores between baseline, 12, and 24 months among individuals enrolled in a randomized controlled trial (RCT); and (2) to highlight insights from youth with lived expertise transitioning to adult healthcare.MethodsThis sub-study of the Transition Navigator Trial, a pragmatic RCT evaluating a patient navigator intervention, examined overall TRAQ scores among 129 participants. Group comparisons used the Mann–Whitney U test, and mixed models with random intercepts assessed associations between navigator access, time, and TRAQ scores. Fifteen youth partners with lived experience contributed perspectives through ongoing meetings and structured reflection on study findings; this involvement constitutes patient-oriented research and should not be interpreted as formal qualitative methodology.ResultsAt baseline, mean TRAQ scores did not differ significantly between intervention and control groups (β=0.05, p = 0.58, 95% CI −0.12, 0.22). Regardless of treatment allocation, mean TRAQ scores increased from baseline to 12 months (β=0.54, p < 0.001, 95% CI 0.44, 0.63) and from baseline to 24 months (β=0.68, p < 0.001, 95% CI 0.59, 0.78).ConclusionsAccess to a patient navigator did not significantly influence TRAQ score trajectories; however, TRAQ scores increased significantly over time in both groups. These findings suggest that transition readiness, as measured by the TRAQ, may improve through lived experience during the transition period regardless of navigator access. Both groups received shared transition-related resources throughout the study, which may have contributed to the observed increases. Notably, the TRAQ was implemented as an indirect parallel measure in this study rather than a primary intervention target, and this should be considered when interpreting the null between-group finding. Partnering with youth enhanced interpretation of findings and underscored the importance of centering lived expertise when evaluating transition readiness outcomes.Keywords: Transition to adult care, Transition readiness, Chronic health condition, Young adult, Patient-centered care Introduction Background Ensuring adolescents and young adults (AYA) have a successful transition to adult healthcare is an essential component of the trajectory of their current and future health and wellness. This transition period is particularly difficult for AYA with chronic health conditions and is characterized by increased emergency room visits, decreased attendance at routine appointments, and poor self-management1, 2, 3. Structured transition supports, such as patient navigation, potentially mitigate adverse outcomes during the transition period. Several systematic reviews have found that comprehensive and structured transition processes are associated with improved health outcomes, including decreased time between last pediatric appointment and first adult appointment, increased patient satisfaction, and increased adherence to health management, as well as reductions in hospital admissions and dropout from adult care 4, 5, 6, 7. AYA often feel unprepared for this transition making appropriate transition preparations crucial8. Transition preparations can be guided by scores on transition readiness assessments. Many readiness assessments exist, and which tool is administered often depends on clinician/researcher preference. These measurements often focus primarily on AYA ability to manage their condition with questions such as “Do you fill a prescription if you need to?”9 and “How hard or easy is it for you to talk to your doctor?” 10. Skill-based questions are helpful for clinicians to determine whether an AYA can safely move to adult care, however transition readiness encompasses much more than these skills. AYA must have adequate motivation, capacity, and social support to minimize adverse health outcomes related to transition11. The Transition Readiness Assessment Questionnaire (TRAQ) has been found to be the most validated readiness measure 12. The TRAQ contains five domains: managing medications, keeping appointments, tracking health issues, talking with providers, and managing daily activities13. The TRAQ has been considered one of the best assessment tools, yet research and clinical questions remain. Longitudinal examination of TRAQ scores is required to investigate the tool’s suitability to predict a successful transition (e.g., adult clinic attendance, hospitalizations). Thus, this study focuses on assessing changes observed in TRAQ scores over time in a randomized controlled trial (RCT) piloting a transition intervention. We hypothesized that TRAQ scores will improve with time in both the intervention and control arms, and that the intervention group will experience a higher rate of change in scores over time. Objectives The objectives of this study were to 1) compare the change in TRAQ scores between baseline, 12 month and 24 month observation points for individuals enrolled in an RCT testing the effectiveness of a patient navigator during transition to adult care compared to usual care, and 2) highlight the insights of youth with lived expertise transitioning to adult healthcare to better understand and contextualize the quantitative outcomes. Methods Study design The Transition Navigator Trial (TNT) used a parallel group, pragmatic RCT design. Detailed study design and description of the interventions is provided in Reference 9 and summarized below. This study has two components: (1) a quantitative analysis of TRAQ scores collected at three time points within the trial, and (2) the incorporation of perspectives from youth partners with lived experience in the healthcare system. Youth partner involvement was conducted as part of a patient-oriented research (POR) approach and does not constitute qualitative research - their contributions informed interpretation of findings and are described further in the Patient Engagement section below. This study was approved by the University of Calgary Conjoint Health Research Ethics Board (REB16-2561) and by the University of Alberta Health Research Ethics Board (Pro00077325). Reporting of this study adheres to the Consolidated Standards of Reporting Trials (CONSORT) guidelines. Patient engagement The Transition Research Advisory Council (TRAC) consisted of 15 youth with lived experience in the health and mental healthcare systems within Alberta who partnered on this work. Guiding principles of patient-oriented research (POR) were applied 14 to engage TRAC members meaningfully throughout this project (Fig. 1). The TRAC involvement included assisting with the write up of background and discussion sections, providing feedback throughout, and editing this manuscript. Throughout the study, all 15 TRAC members contributed perspectives through ongoing meetings and, following the completion of quantitative analyses, through a Google Form containing reflection questions about the findings. Responses were not subject to formal qualitative analysis; rather, selected quotes are presented as provided to illustrate youth perspectives. This does not constitute qualitative research data and should not be interpreted as such. Canadian Institute for Health Research Guiding Principles of Patient Oriented Research. Population and setting Study data was derived from the TNT; a pragmatic RCT in Alberta testing the effectiveness of a patient navigator intervention for AYA with chronic health conditions transitioning to adult healthcare. Eligible participants were identified from 41 pediatric specialty clinics across the three participating hospitals, spanning a broad range of chronic health conditions including endocrine, gastrointestinal, neurological, neurodevelopmental, rheumatological, renal, cardiac, hematological, respiratory, and metabolic/genetic conditions. Participants were recruited through three methods: clinic staff identifying potential participants and requesting consent to be contacted by the study team, direct self-referral via a study email or phone number advertised through recruitment posters, and mail-outs to potentially eligible participants who had used health services at the participating hospitals. Eligibility screening was conducted by trained research assistants in person or by phone. AYA enrolled in this trial were between 16 and 21 years of age and were recruited from three tertiary care pediatric hospitals in Alberta. There were 335 AYA in the trial with 164 assigned to the intervention arm. Participants were followed by the patient navigator for a minimum of 12 months and a maximum of 24 months. The patient navigators were registered social workers with at least five years of clinical experience, employed by Alberta Health Services. One patient navigator was in Edmonton and one in Calgary, the two cities having tertiary care centers. Demographic data were collected from participants at the time of enrollment via an online survey administered through REDCap. Variables collected included age, primary disease, socioeconomic status, location of residence, medical and mental health comorbidity, ethnicity, and immigrant status. These variables were used to characterize the sample and assess baseline balance between intervention and control groups. Inclusion & exclusion Participants were eligible for the TNT based on the following inclusion criteria 15: 16–21 years of age at enrollment; receiving care from at least one of three pediatric outpatient hospitals and community clinics (Glenrose Rehabilitation Hospital, Stollery Children’s Hospital, Alberta Children’s Hospital); have a chronic medical condition (defined as conditions which are >3 months in duration and/or lifelong with multiple morbidities and/or multi-organ/system manifestations or conditions which typically affect a single organ/system); and expected to be transferred to adult specialty care within the next 12 months. In Alberta, Canada, transfer from pediatric to adult care is governed by age-based clinic policies rather than individual assessments of maturity or transition readiness. As such, the determination that a participant was 'expected to be transferred to adult specialty care within the next 12 months' was based on age-related cut-offs specific to each participating clinic and did not reflect a judgment about the participant's preparedness for transition. Exclusion criteria were as follows 15: enrolled in another transition-related study involving a navigator or similar intervention; transfer not anticipated during the time interval for the study; will be moving out of Alberta during the time of the study; inability to read and write in English. For this analysis, participants were eligible for inclusion if they had completed the TRAQ at baseline and at least one other time point (12 or 24 months). Any TRAQs completed by a caregiver, on behalf of the AYA, were excluded. Intervention The TNT intervention is described in detail in Samuel et al.15 and summarized here. The intervention was access to a patient navigator service. We used a stratified randomization sequence allocation (based on primary clinic affiliation) to the intervention or control arm. Intervention assignments were not blinded to trial participants, caregivers, research staff, or clinic teams. The intervention was designed to overcome barriers and challenges related to transitioning to adult care by facilitating a coordinated entry into the adult system, to increase the appropriate use of adult-oriented ambulatory primary and specialty care and reduce emergency department/urgent care visits. The patient navigator personalized their support towards the needs of individuals guided by four overarching modules: (1) preparation for the transfer of care, including completing transition readiness assessments and creating a medical passport; (2) acting as a health systems broker to facilitate continuity of care between pediatric and adult providers; (3) assistance with social determinants of health to reduce modifiable barriers to accessing adult care; and (4) promotion of self-management of medical conditions, including coaching on medication adherence and appointment attendance. Following randomization, navigators contacted participants within 7 days to schedule an initial meeting. Ongoing support was delivered via telephone, text, email, or in-person visits, with scheduled reviews every 3 months over the 24-month intervention period. The frequency and mode of contact varied based on individual participant needs, ranging from weekly in-person meetings to quarterly phone calls, reflecting the person-centered nature of the intervention15. AYA assigned to the control group received care as usual within adult and pediatric clinics and the health region. These included attendance at transition clinics, and access to available transition websites, self-management tools, and workshops. All participants in the TNT, regardless of group assignment, received six periodic newsletters via email from the TNT research team with transition-related resources including AYA-oriented transition websites, self-management tools and the opportunity to attend transition-focused workshops. Outcome measures The primary outcome was overall TRAQ scores at the following time points: baseline, 12, and 24 months. TRAQ 5.0 is a self-report questionnaire consisting of 29 items and are scored on a 1 (low) to 5 (optimal) (1 = “No, I do not know how”; 2 = “No, but I want to learn”; 3 = “No, but I am learning to do this”; 4 = “Yes, I have started doing this”; 5 = “Yes, I always do this when I need to”)9. The TRAQ was completed on a REDCap16, 17 form and distributed via email. Overall TRAQ scores were an average of all subscales for a summative transition readiness score. Covariates Based on available data and previous literature, we explored the effects, and adjusted for sex (biological), age, immigration status, and ethnicity as covariates. If the individual adjustment of each covariate did not impact the effect estimate, they were removed from the final model. Analytic procedure Means, medians, and proportions with appropriate interquartile ranges (IQR) were used to describe the demographics and baseline clinical characteristics of the trial participants. To ensure the randomization was successful in this subsample, demographic and clinical characteristics were compared between intervention and control groups using T-tests (continuous variables) and chi-square tests (categorical variables). To address the potential impact of missing covariates and outcome data on TRAQ scores, we also used T-tests and chi-square tests. We compared median TRAQ scores between patient navigator and usual care cohorts at each time point (0, 12, 24 months), using Mann-Whitney U test as the data was not normally distributed. Given the use of longitudinal, repeated-measures data, a mixed-model analysis with random intercepts was used to explore the relationship between access to a patient navigator, time, and TRAQ scores. To address non-linearity, two categorical time indicators were used to allow for the slope for baseline to 12 months to differ from that of 12 months to 24 months. Interaction terms were generated between time and access to a patient navigator to investigate their potential combined effect on TRAQ scores. Likelihood ratio tests were utilized to compare the fit of nested models. All statistical analyses were conducted using Stata V.1718. An alpha of 0.05 was set for statistical significance. Results There were 335 AYA enrolled in the TNT, with 164 assigned to the patient navigator and 171 in the control arm. A total of 129 participants met inclusion criteria for this analysis (Fig. 2). The demographic and clinical characteristics are outlined in Table 1. There were no statistically significant differences between the characteristics of the intervention and control groups, indicating randomization was successful in this sample. The mean age for this sample was 16.9 (SD= 0.57) years for the intervention and 17.1 (SD=0.56) years for the control, with 58% (intervention) and 42% (control) identifying as female. The largest proportion of our sample was white (69% and 66% respectively). CONSORT diagram of eligible participants. Table 1Demographic and clinical characteristics.CharacteristicIntervention (N = 59)Control (N = 70)Age, mean (SD)16.9 (0.6)17.1 (0.6)Sex, n (%) Male25 (42)28 (40) Female34 (58)42 (60)Ethnicity, n (%) White41(69.5)46 (65.7) Black2 (3.4)3 (4.3) First Nations/Indigenous3 (5.1)5 (7.1) Other13 (22.1)16 (22.9)Immigrant, n (%)10 (16.9)9 (12.8)Self-reported mental health comorbidity, n (%)48 (36.9)54 (35.8)Primary Diagnosis Category, n (%) Genetic/Metabolic3 (0.05)0 (0.00) Neurological8 (0.13)9 (0.13) Cardiovascular8 (0.13)8 (0.12) Respiratory0 (0.00)5 (0.07) Renal/Urinary Tract4 (0.06)5 (0.07) Gastrointestinal/Liver9 (0.15)10 (0.14) Hematology/Immune deficiency3 (0.05)4 (0.06) Rheumatology11 (0.18)19 (0.27) Endocrine8 (0.13)6 (0.09) Mental Health3 (0.05)3 (0.04) Developmental0 (0.00)0 (0.00) Sensory1 (0.01)1 (0.01) Other1 (0.01)0 (0.00) Demographic and clinical characteristics. There was considerable attrition present in this study. At baseline, there was a 92% completion rate of the TRAQ in Calgary and 85% in Edmonton. At 12 months, 53% of participants in Calgary and 55% of participants in Edmonton completed the TRAQ. Finally, at 24 months 38% completion in Calgary and 46% in Edmonton. A small proportion of sex, age, ethnicity, and immigration status variables were missing (less than 5%). There was no significant relationship between missing baseline TRAQ scores and covariates (sex, age, ethnicity, immigration status); as such, missing TRAQ scores were considered missing completely at random (MCAR). While there may be patterns of missingness that this analysis did not detect, to the extent that the included covariates explain these patterns, the mixed model is considered to be an effective strategy for handling missing data under the missing at random assumption 19. The median TRAQ scores with IQRs are presented in Table 2. The Mann-Whitney U demonstrated that there was no significant difference between groups at any of the time points (baseline p = 0.99, 12-month p = 0.36, 24-month p = 0.07) (Fig. 3). A ceiling effect (achieving the maximum score of five) was observed in 3% of participants at 12-months and 9% at 24-months. Table 2Median TRAQ scores and IQR by allocation group.MedianIQRBaseline Control3.65Q1 = 3.3, Q3 = 3.9 Intervention3.62Q1 = 3.2, Q3 = 4.212 Month Control4.05Q1 = 3.9, Q3 = 4.5 Intervention4.17Q1 = 3.8, Q3 = 4.724 Month Control4.21Q1 = 3.8, Q3 = 4.6 Intervention4.27Q1 = 4.1, Q3 = 4.8 Median TRAQ scores and IQR by allocation group. Boxplots TRAQ scores over time between groups. Using the mixed model analysis, we first explored the association between allocation, time, and TRAQ scores with two interaction terms to represent the effect of allocation on the mean difference in TRAQ scores at 12 months and 24 months. These interaction terms would indicate the difference in the effect of allocation at the respective timepoint in comparison to the baseline. We then ran the analysis without the interaction terms followed by a likelihood ratio test to determine the best fit model to proceed with. The model including time and allocation (but not the interaction terms) did not have a significantly worse fit than the model with interaction (p = 0.18), indicating that TRAQ score improvement over time is not significantly different depending on allocation. As such, the interaction terms were left out of the final analysis. At baseline, there was no significant difference in mean TRAQ scores between the intervention and control group (β=0.05, p = 0.58, 95% CI −0.12, 0.22). Irrespective of treatment allocation, mean TRAQ scores did increase over time between both baseline to 12 months (β=0.54, p < 0.001, 95% CI 0.44, 0.63), and baseline to 24 months (β =0.68, p < 0.001, 95% CI 0.59, 0.78) (Table 3). Table 3Results of analysis showing relationship between TRAQ scores, time, and allocation.TRAQ ScoreCoefficient (95% CI)P > |z|*SEMean Difference in TRAQ Scores between Allocation Groups at 0 months0.05 ( −0.12, 0.22)0.580.09Mean Difference in TRAQ Scores Between 0 and 12 Months0.53 (0.44, 0.63)0.0010.05Mean Difference in TRAQ scores Between 0 and 24 Months0.68 (0.59, 0.78)0.0010.05 Results of analysis showing relationship between TRAQ scores, time, and allocation. We conducted this study in partnership with youth having lived experience with transition. Youth partners reflected on why the TRAQ scores may have changed over time based on their own experiences. They also described ways in which a more diverse population may expand our understanding of TRAQ score trajectories. Further reflections are provided in Table 4, which are direct quotations from youth partners. Table 4Patient partners reflections on study results.Results Interpretation QuestionsReflections (Direct quotes)Based on lived experience, what do the results mean?•“TNT may not improve TRAQ scores and AYA gain readiness through experiences which account for improved TRAQ scores.”•“The first 12 months results in many new experiences for patients transitioning, causing them to learn, and manage their conditions independently, thus, increasing their TRAQ scores.”•“AYA gain experience performing the task (managing medications, appointment tracking, talking to providers, etc.) that would have independently increased their TRAQ score at 24 months for both groups.”Based on lived experience, did you increase readiness between pre-transition to 12 months or from 12 to 24 months?•“The first 12 months are the initial experience in the adult system, where the most amount skills are gained and readiness is increased the most.”•“During the 12 months one must first determine what they are able to manage, what they need to learn, then seek out resources to help them be successful the second time.”Why do you believe there was no significant change in scores between the intervention and control group?•“The multitude of “first” experiences (i.e. adult appointment) in the initial 24 months of transition explains the lack of significance. AYA identify their needs, and respond accordingly. The lived experience of those initial experiences are similar thus potentially explaining the lack of significance.”Does anything in the data speak out to you?•“More representation for Black and Indigenous populations may provide more insight into the systemic equities these populations face, especially in regards to the patient TRAQ scores.”What are the practice implications?•“More research is needed to validate Patient Navigator Service and TRAQ scores to determine long term impact.”o“Consider including the Patient Navigator Service routinely for AYA at 16 years old.” Patient partners reflections on study results. •“TNT may not improve TRAQ scores and AYA gain readiness through experiences which account for improved TRAQ scores.” “TNT may not improve TRAQ scores and AYA gain readiness through experiences which account for improved TRAQ scores.” •“The first 12 months results in many new experiences for patients transitioning, causing them to learn, and manage their conditions independently, thus, increasing their TRAQ scores.” “The first 12 months results in many new experiences for patients transitioning, causing them to learn, and manage their conditions independently, thus, increasing their TRAQ scores.” •“AYA gain experience performing the task (managing medications, appointment tracking, talking to providers, etc.) that would have independently increased their TRAQ score at 24 months for both groups.” “AYA gain experience performing the task (managing medications, appointment tracking, talking to providers, etc.) that would have independently increased their TRAQ score at 24 months for both groups.” •“The first 12 months are the initial experience in the adult system, where the most amount skills are gained and readiness is increased the most.” “The first 12 months are the initial experience in the adult system, where the most amount skills are gained and readiness is increased the most.” •“During the 12 months one must first determine what they are able to manage, what they need to learn, then seek out resources to help them be successful the second time.” “During the 12 months one must first determine what they are able to manage, what they need to learn, then seek out resources to help them be successful the second time.” •“The multitude of “first” experiences (i.e. adult appointment) in the initial 24 months of transition explains the lack of significance. AYA identify their needs, and respond accordingly. The lived experience of those initial experiences are similar thus potentially explaining the lack of significance.” “The multitude of “first” experiences (i.e. adult appointment) in the initial 24 months of transition explains the lack of significance. AYA identify their needs, and respond accordingly. The lived experience of those initial experiences are similar thus potentially explaining the lack of significance.” •“More representation for Black and Indigenous populations may provide more insight into the systemic equities these populations face, especially in regards to the patient TRAQ scores.” “More representation for Black and Indigenous populations may provide more insight into the systemic equities these populations face, especially in regards to the patient TRAQ scores.” •“More research is needed to validate Patient Navigator Service and TRAQ scores to determine long term impact.”o“Consider including the Patient Navigator Service routinely for AYA at 16 years old.” “More research is needed to validate Patient Navigator Service and TRAQ scores to determine long term impact.”o“Consider including the Patient Navigator Service routinely for AYA at 16 years old.” o“Consider including the Patient Navigator Service routinely for AYA at 16 years old.” “Consider including the Patient Navigator Service routinely for AYA at 16 years old.” Discussion This study sought to examine the change in TRAQ scores in a longitudinal study between those assigned to a patient navigator intervention versus care as usual. We found that access to a patient navigator intervention did not significantly impact the rate of change in TRAQ scores. Aligned with the existing research, our results demonstrate that over time, TRAQ scores increase 20, 21, 22, 23. The baseline TRAQ scores in our sample were similar to those in previous studies 9, 20, 24. The developers of the TRAQ state when AYA are consistently performing the skills measured across the four domains of TRAQ with at least a maintenance score of 4.0, they are ready for the transition 9. In our sample, only 56% of AYA were scoring > 4.0 by 24-months post enrollment into the study, which is between one to two years after their transition to adult care (depending on their age at baseline). This study utilized TRAQ 5.0, which reflects the updated and psychometrically improved version of the tool validated by Wood et al. in 20149. This version demonstrated improved factor structure, reliability, and validity compared to the original 2009 version, supporting its use as a robust measure of transition readiness in this study. To our knowledge, this is the first study to assess TRAQ scores over time in an RCT with a truly non-disease specific population. The findings of the current study differ from previous research in this area. The available literature utilizing the TRAQ as an outcome measure are limited to specific chronic conditions. For example, Mackie et al.25, implemented a nurse-led educational intervention for AYA with congenital heart disease (CHD). The authors found that TRAQ self-advocacy scores had no difference between intervention and control groups, however, for TRAQ self-management scores, the intervention group had statistically significant higher scores than the control at 6 months (p = 0.048)21, 25. This study stratified the analysis by self-advocacy and self-management, which makes it difficult for us to compare our results of overall TRAQ scores. Al Ksir et al.22., explored the impact of motivational interviewing on AYA with type one diabetes and found mean TRAQ scores in the intervention group increased significantly from baseline to 6 months (p < 0.001). The contradiction of our findings with previous studies can be explained by our heterogeneous study population and the variation in our intervention, which both can lead to a dilution of treatment effects. When assessing transition readiness in disease-neutral groups, there will be a wide range of readiness, which can lead to variability in the range of scores and readiness levels reported. The nature and dosage of the intervention in the TNT was much different than that of previous studies. Previous studies have had prescriptive dosages of the intervention (e.g., two one-hour visits for all intervention participants) whereas TNT varied greatly. All intervention participants worked with the patient navigator for 24-months, but the frequency and amount of contact differed. Some participants met with the patient navigator in-person weekly, whereas others had a quick phone call every three months. Additionally, the previous interventions have focused almost entirely on the development of self-management skills and improvement in TRAQ scores20, 21, 22, 26. It is important to acknowledge that the TNT intervention was broad in scope, addressing health system barriers, social determinants of health, and self-management across a wide range of individual needs. Transition readiness, as measured by the TRAQ, represented one component of the navigator's role rather than its primary focus. Notably, navigators did administer the TRAQ with participants as a clinical tool to guide individualized transition conversations, providing a direct link between the intervention and the outcome measure. However, the person-centered nature of the intervention meant that the degree to which each navigator focused on TRAQ-specific skills varied considerably across participants. This misalignment between the breadth of the intervention and the specificity of the TRAQ as an outcome measure should be considered when interpreting the null finding. It is also possible that the intervention was effective in impacting readiness, but the TRAQ failed to capture its effect on transition readiness. An additional consideration when interpreting the null between-group finding is that both intervention and control participants received transition-related resources throughout the study, including periodic newsletters, access to AYA-oriented transition websites, self-management tools, and the opportunity to attend transition-focused workshops. These shared resources may have independently contributed to improvements in TRAQ scores across both groups, reducing the likelihood of detecting a between-group difference. This design feature, while intentional to ensure ethical provision of care to all participants, should be considered when interpreting the observed increases in TRAQ scores across the full sample. Our partnerships with the TRAC yielded novel insights to the process of collaborating with youth on a quantitative study. Similar to other key studies in POR 27, 28, youth partners had flexibility and autonomy over their involvement in this project. However, there is a gap in literature related to how to best engage patient partners in quantitative research. All 15 TRAC members contributed throughout the study through ongoing meetings, and following the completion of quantitative analyses, provided reflections on the findings via a structured Google Form. Their involvement was conducted as patient-oriented research and should not be interpreted as qualitative methodology. Our partnerships demonstrated how youth can be involved in a quantitative project in ways that are meaningful and valuable to them, and ensured that data interpretation was grounded in lived experience. Youth partners indicated interest in working on the study design, interpretation of findings, and co-writing this manuscript. The TRAC partners also demonstrated a keen interest in learning about statistical analysis and modeling techniques, indicating a desire for increased knowledge and skill development in this area. The partnership ensured that our data, interpretations, and future directions were backed by lived experiences and held importance to this population. The reflections posed by partners elicited nuanced information about our findings that may otherwise be unexplored. For example, in Table 4, one TRAC member shared why TRAQ scores could increase more from baseline−12 months compared to baseline−24 months, based on their experience with developing readiness skills. The successful partnerships in this study highlight the importance of including youth voices in all research studies, not only those using qualitative data. Additionally, by providing AYA with autonomy in their choices related to involvement in the project, we were able to maintain their interest and engagement while ensuring that project requirements were met. Strengths and limitations The results of this study offer a unique contribution to the literature as the utilization of the TRAQ in a disease neutral RCT have not been well studied. This is a strength as it provides a novel insight to the utility and effectiveness of the TRAQ in assessing transition readiness over time with a range of chronic conditions. Additionally, the use of a RCT contributed to the robustness of our findings. Our study was protected from selection bias29 as allocation was not dependent on the outcomes. Further, allocation was conducted after participants consented to participate in the trial, mitigating the possibility of selective non-consent based on treatment assignment29. A key strength of this study was the utilization of POR. There is a shortage of literature on patient, specifically youth, engagement in strictly quantitative research. Our partnerships demonstrated how youth can be involved in a quantitative project, in ways that are meaningful and valuable to them. Youth partners reflected on the quantitative data and provided insights that would have otherwise gone undetected, which increased the relevance and quality of our findings. This study is not without limitations. First, we acknowledge the presence of a type II error is possible and therefore encourage future research to explore this association with a larger sample size and higher completion rates. This study would provide preliminary data to test these associations. The TNT was conducted within a clinical setting and our sample was representative of the population in Alberta, Canada, however, the findings should be generalized with caution to other populations. Due to our sample size and availability of data, we were not able to analyze the data stratified by certain demographic characteristics (e.g., immigrants, low income, ethnicity) which are all areas that warrant further exploration. Additionally, AYA with neuro-developmental conditions that were unable to complete the TRAQ independently (N = 11) were excluded as the TRAQ is not yet validated for a proxy report of readiness. This exclusion limits our understanding of the progress of readiness in these youth and ultimately, impacts the generalizability of the findings to AYA with neuro-developmental conditions. There were three important sources of bias in this study. As we utilized survey data (TRAQ, demographics survey), this data is subject to social desirability bias30. Participants completed the surveys online and independently - without the presence of their physician or the research coordinator – which may have reduced the likelihood of social desirability bias31. Attrition is acknowledged as an important limitation of this study, with completion rates declining from 92% at baseline to 38–46% at 24 months. However, several design features and analytical decisions mitigate the potential impact of attrition on the validity of our findings. First, our analysis of missingness did not identify departures from missing completely at random, suggesting that dropout was not systematically related to TRAQ scores and therefore is unlikely to have introduced substantial attrition bias. Second, we used an additional analysis adjusting for missingness as a covariate, which did not meaningfully alter our results 32. Third, our use of mixed models with random intercepts allowed all available data to be included in the analysis, maximizing the use of observed data rather than relying solely on complete cases. While attrition limits the generalizability of our findings and the precision of our estimates, we do not believe it fundamentally undermines the internal validity of the study. Additionally, more granular data on navigator contact frequency and content, online resource engagement, and transition workshop attendance were not collected as part of this sub-study and therefore could not be used to stratify analyses by level of intervention receipt. Future research should consider prospectively capturing these implementation fidelity data to enable more detailed examination of dose-response relationships between navigator contact and transition readiness outcomes. Conclusion This study found that access to a patient navigator did not significantly influence TRAQ score trajectories over 24 months, while TRAQ scores increased significantly from baseline in both intervention and control groups. These findings suggest that transition readiness, as measured by the TRAQ, may improve through lived experience during the transition period regardless of navigator access. Despite the limitations of this study, these findings highlight important gaps in our understanding of the TRAQ as an outcome measure in transition interventions. This serves as a call to action for healthcare providers working with this population to use transition assessments not merely as outcome measures, but as guides for meaningful discussion while collaborating with AYA to develop individualized transition preparations. Funding Funding was provided by the Canadian Institutes for Health Research (10026726) and a Department of Pediatrics Innovation Award (10009293) at the University of Calgary. Infrastructure support was provided by the Alberta SPOR Support Unit Data Research Platform. Ethical Statement Ethics approval was granted from the University of Calgary Conjoint Health Research Ethics Board (REB#162561) and University of Alberta Research Ethics Board (Pro0077325). All trial participants provided informed consent. CRediT authorship contribution statement Zoya Punjwani: Writing – review & editing, Formal analysis. Cassandra Chisholm: Writing – review & editing. Megan Patton: Writing – review & editing, Writing – original draft, Formal analysis, Data curation, Conceptualization. Susan Samuel: Writing – review & editing, Supervision, Investigation, Conceptualization. Gina Dimitropoulos: Writing – review & editing, Supervision, Investigation, Conceptualization. Samantha J. Anthony: Writing – review & editing, Supervision. Daniella San-Martin Feeney: Writing – review & editing, Project administration, Investigation. Scott Patten: Writing – review & editing, Supervision, Formal analysis. Andrew S. Mackie: Writing – review & editing, Supervision, Investigation, Conceptualization. Declaration of Competing Interest The authors declare that they have no competing interests. No sponsor had any role in the study design; collection, analysis and interpretation of data; in the writing of the report; or the decision to submit the article for publication. Acknowledgments We thank all the participants and parents who participated in the study. We acknowledge the contributions made by leadership of Alberta Health Services in both Calgary and Edmonton to help facilitate establishing and hiring into the navigator positions within each of Alberta Children’s Hospital and Stollery Children’s Hospital. We thank the social work clinicians who served as navigators during the study. This project was supported by funding obtained by Megan Patton from the Canadian Institutes of Health (CIHR)’s Graduate Scholarship- Masters. Trial Registration NCT03342495 Footnotes Supplementary data associated with this article can be found in the online version at doi:10.1016/j.hctj.2026.100143. Supplementary material Supplementary material Data availability Data will be made available on request. References Associated Data Supplementary Materials Supplementary material Data Availability Statement Data will be made available on request.